Both in Pharmaceuticals
Opko Health vs UroGen Pharma
Over the past year OPK returned +21.6% and URGN returned +32.3%; their daily moves had a correlation of 0.11.
OPK +21.6% URGN +32.3%Growth of $1, one year, split-adjusted
| Metric | OPK | URGN |
|---|---|---|
| Price | $1.69 | $26.21 |
| Market cap | $1.26B | $1.29B |
| Today | −4.47% | −8.80% |
| 1 month | +21.6% | −35.6% |
| 6 months | +51.0% | −1.4% |
| Year to date | +34.2% | +11.9% |
| 1 year | +21.6% | +32.3% |
| Revenue growth (YoY) | +4.3% | +199.2% |
| Gross margin | 48.9% | 90.9% |
| Net margin | −5.1% | −19.8% |
| P/E (TTM) | — | — |
| Price / sales | 2.1× | 6.8× |
| Net cash | -$46.5M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | 58.5% | 56.6% |
| Short % of float | 9.3% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).